Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials

Alexander J Goss, Muzaffer Kaser, Sergi G Costafreda, Barbara J Sahakian, Cynthia H Y Fu

Research output: Contribution to journalArticlepeer-review

114 Citations (Scopus)

Abstract

Current pharmacologic treatments for a depressive episode in unipolar major depressive disorder (MDD) and bipolar depression are limited by low rates of remission. Residual symptoms include a persistent low mood and neurovegetative symptoms such as fatigue. The objective of this study was to examine the efficacy and tolerability of augmentation of first-line therapies with the novel stimulant-like agent modafinil in MDD and bipolar depression.
Original languageEnglish
Article numberN/A
Pages (from-to)1101-1107
Number of pages7
JournalPRIMARY CARE COMPANION TO THE JOURNAL OF CLINICAL PSYCHIATRY
Volume74
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Dive into the research topics of 'Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Cite this